Noble Financial analyst Poe Fratt maintained a Buy rating on Gevo (NASDAQ:GEVO) on Wednesday, setting a price target of $16, which is approximately 188.29% above the present share price of $5.55.
Fratt expects Gevo to post earnings per share (EPS) of -$0.07 for the fourth quarter of 2021.
The current consensus among 2 TipRanks analysts is for a Moderate Buy rating of shares in Gevo, with an average price target of $17.
The analysts price targets range from a high of $18 to a low of $16.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $142 thousand and a net profit of -$14.53 million. The company's market cap is $1.12 billion.
According to TipRanks.com, Noble Financial analyst Poe Fratt is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 41.4% and a 54.51% success rate.
Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company's isobutanol technology. The Gevo Development and Agri-Energy segment is currently responsible for the operation of its agri energy facility and the production of ethanol, isobutanol, and related products. The company was founded by Matthew W. Peters, Peter Meinhold, and Frances Hamilton Arnold on June 9, 2005 and is headquartered in Englewood, CO.